P1054 (10138): Assessment of Safety and Toxicity Among Infants Born to HIV-Infected Women Enrolled in Antiretroviral Treatment Protocols in Diverse Areas of the World

Study Status Study Restriction

Concluded

US & Non-US

What is P1054?

A5190/P1054 was a prospective, observational, cohort study of infants born to HIV-1-infected women while enrolled in NIH-sponsored, international, antiretroviral (ARV) treatment protocols (for example, A5175, HPTN 052, P1032, A5207, A5208, and other future studies). These infants were enrolled into A5190/P1054 and followed prospectively to describe the safety, toxicity, and potential side effects of in utero and breast milk exposure to the ARV drugs used in international treatment protocols.

Study Documents:

Sites where the study was implemented:

CRS ID Site Name City Country

5117

Hospital Nossa Senhora da Conceicao CRS

Porto Alegre

Brazil

       

  Study Contacts

Clinical Trials Specialist: Kimberly Hudgens

CTS: IMPAACT Operations Center

Department of Health and Human ServicesNational Institutes of Health

Funded by the National Institute of Allergy and Infectious Diseases, the Eunice Kennedy Shriver National Institute of Child Health and Human Development, and the National Institute of Mental Health of the US National Institutes of Health, US Department of Health and Human Services.